BioNexus Gene Lab Corp 10-Q filing
Filed 2025-11-14 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001477932-25-008343
- Form type
- 10-Q
- CIK
- 0001737523
- Primary document
- https://www.sec.gov/Archives/edgar/data/1737523/000147793225008343/bglc_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioNexus Gene Lab Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $6.9M | - | - |
| Cost Of Revenue | $5.9M | - | - |
| Gross Profit | $1.1M | - | - |
| Operating Income | $-1.9M | - | - |
| Net Income | $-1.9M | - | - |
| Eps Diluted | -1.085 | - | - |
| Total Assets | $7.6M | - | - |
| Total Liabilities | $804,966 | - | - |
| Shareholders Equity | $6.8M | - | - |
| Operating Cash Flow | $-2.8M | - | - |
| Capital Expenditures | $35,994 | - | - |